Cox-II Inhibitors
COX II Inhibitors Side Effects May Lead To Heart Attack Lawsuits
COX II inhibitors | Lawsuits, Lawyers | Side Effects: Cardiovascular Events, Heart Attack, Strokes
COX II inhibitors are a relatively new family of nonsteroidal anti-inflammatory drugs ( NSAIDS). There is a controversy surrounding the use of COX II inhibitors. Scientists believe that their use is associated with an increased risk of cardiovascular events such as heart attack and stroke.
All NSAID drugs (even the newer ones like Vioxx and Bextra) cause irritation, ulceration, bleeding and perforation of the lining of the stomach and blood clotting. Merck's aggressive promotional campaign quickly boosted Vioxx into the top 20 U.S. drugs. It has been among the drugs most heavily advertised to doctors and patients alike.
Vioxx users doubled their risk of heart attack and stroke, abruptly pulled the drug from the world market. Days later, the Wall Street Journal reported on an analysis never made public by a safety official at the U.S. Food and Drug Administration. The study, examining data on 1.4 million Kaiser Permanente members, drew this conclusion: More than 27,000 heart attacks and sudden cardiac deaths.
Bextra has been linked to Heart Attack, Stroke and Stevens Johnson Syndrome. Recent reports show that Bextra may be more likely to cause Heart Attacks and Stroke than Vioxx. Additionally, Pfizer has recenty said they will most likely add a black box warning to Bextra about Stevens Johnson Syndrome.
Bextra is a COX-2 inhibitor, marketed by Pharmacia Corporation and Pfizer Inc. in the United States. The drug is prescribed for the treatment of osteoarthritis, adult rheumatoid arthritis, and the pain associated with menstrual cramping.
Legal Help For Victims Affected By COX II Inhibitors
If you or a loved one took COX II Inhibitors and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us at 1-800-LAW-INFO (1-800-529-4636).
